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THIS
ARTICLE HAS 3 objectives: (1) to differentiate an from attention to acute disease. 2 Acute diseases can typically outcomes model from a traditional biomedical model; (2) be diagnosed and successfully treated (or sometimes they will to determine whether the traditional model leads to overdiagget better on their own). These problems are often identified nosis and, perhaps, to excessive costs in health care; and (3) to through a biologic test. With good testing, how patients report propose that new methods of medical decision making, involvthe experience may be of little value. Most of the information ing both patients and providers, can contribute to the solutions required to diagnose and treat the condition can be identified in for these problems, the laboratory.The acute disease model dominateshow we have developed health care, including the construction of hos-MODELS pitals, the development of training programs, and the creation of medical subspecialties. 2 The difficulty is. that, since about The Biomedical and Outcomes Model 1950, the major burden on our health care system has been
Medicine and clinical psychology are based on the art of chronic disease) Chronic diseases typically have multiple causes, and most diagnosis and treatment. Preventive health care is often repeople who have 1 chronic condition typically have other chronic diseases as well. The Medical Outcomes Study, for example, recruited patients who had 1 of 6 chronic disease From theDepartment of Family andPreventive Medicine, University ofCalifornia, states. However, over 90% of the participants had other chronic sanDiego, CA.
conditions in addition to that which placed them in a category Supported in part by the Agency for Healthcare Research and Quality (grant no.
for the study. 4 In contrast to acute diseases that last for a brief the condition and adaptation to the problem cannot be ignored.
Presented in part at Quality of Life Measurement: Building an Agenda for the
The outcomes model also places greater emphasis on epide- Research. 2o One of the most important differences is in how the models One approach consistent with both the outcomes model and define a unit of benefit. The traditional model usually, links the rehabilitation research tradition is the estimate of benefits in benefit to changes related to a diagnosis. For example, outcome terms of quality_adjusted life years (QALYs). However, demight be assessed by changes in blood pressure, tumor size, or spite the popularity of QALYs in many areas of medicine, there death from a specific disease. The traditional biomedical model have been relatively few applications of it in rehabilitation often focuses on the small picture at the expense of avoiding medicine. For example, a recent search using PubMed identithe big picture. Much of contemporary preventive cardiology is fled about 1500 publications concerning QALYs. Among based on observations from the Coronary Primary Prevention these, only a handful was relevant to rehabilitation medicine. Trial (CPPT). 7 In this experimental trial, men were randomly QALYs are used in quality-adjusted survival analysis, which is assigned to take either a placebo or a drug known as cholestyraa refinement of generic survival analysis. In traditional Survival mine. Cholestyramine can significantly lower serum cholesanalysis, those who were alive are statistically coded as 1.0, terol and, in this particular trial, produced an average total whereas those who are dead are statistically coded as 0.0. cholesterol reduction of 8.5%. In comparison to men using Mortality can result from any disease, and survival analysis placebo, men in the treatment group experienced 24% fewer allows comparisons between different diseases. For example, heart attack deaths and 19% fewer heart attacks, the life expectancies for those who will die from stroke can be One of the crucial features that differentiate the outcomes compared with the life expectancy of those who may die as a model from the traditional biomedical model is how each result of spinal cord injury (SCI). The advantage of these measures the outcome. The CPPT showed a 24% reduction in generic measures over disease-specific measures of brain or cardiovascular mortality in the treated group. The absolute central nervous system function is that general comparisons of proportion of patients who died from cardiovascular disease life expectancy can be considered. The disadvantage is that all was similar in the 2 groups. In the placebo group, there were 38 individuals who are alive are considered equal. A person condeaths among 1900 participants (2%). In the cholestyrmanine fined to home because of severe cognitive limitations is scored i group, there were 30 deaths among 1906 participants (1.6%).
just as someone who is active and participating in activities. I In other words, taking medication for 6 years reduced the Utility assessment allows the quantification of levels of well-I chances of dying from cardiovascular disease from 2% to ness on the continuum anchored by death and wellness: 21 i 1.6%.
In the 1990s, the US Department of Health and Human ! The diagnosis-specific medical model focuses on cardiovasServices (DHHS) convened an expert panel to set standards for cular deaths because the medicine was designed to reduce cost-effectiveness analysis in medicine and health care. The deaths from heart disease. Considering all causes of death, panel suggested that outcomes be measured by using QAEYs, / there was essentially no benefit of treatment. At the end of the which are measures of life expectancy with adjustments for I study, 3.7% of those in the placebo group had died and 3.6% of QOL. n,z2 QALYs integrate mortality and morbidity to express those in the cholestyrmanine group had died. Cholesterol lowhealth status in terms of equivalents of well years of life. If a ering by using cholestyrmanine may reduce the chances of woman dies of stroke at age 50 and one would have expected dying from heart disease, but it is less clear that it reduced the her tO live to age 75, the disease was associated with 25 lost life chances of dying prematurely. The outcomes model does not years. If 100 women died at age 50 (and also had a life take cause of death into Consideration. From the outcomes expectancies of 75y), 2500 (100×25y) life years would be lost. perspective, the focus is on whether the patient is alive. 8 
If a
Death is not the only outcome of concern in stroke. Many medication reduces the chances of dying from 1 disease while adults continue to suffer from the disease, leaving them someincreasing the chances of dying of another, it is not regarded as what disabled over long periods. Although still alive, the qualeffective. 9 Because virtually all treatments have the potential to ity of their lives has diminished. QALYs take into considerproduce harm as well as benefit, the outcomes model may be ation the QOL consequences of these illnesses. For example, a the most appropriate to evaluate benefits of treatment, disease that reduces QOL by 50% will take away 0.5 QALYs The outcomes model is consistent with the Healthy People over the course of 1 year. If it affects 2 people, it will take away 2020 report. The primary public health objective for the United 1 QALY (2× 0.5) over a 1-year period, A rehabilitation treatStates is to decrease disability and increase longeyity, lo Many ment that improves QOL by 0.2 for each of 5 individuals will of these approaches attempt to summarize health by using 1 result in the equivalent of i QALY if the benefit is maintained overall index number. Several approaches to measuring health over a 1-year period. The basic assumption is that life years can outcome attempt to aggregate measures of morbidity and morbe adjusted for QOL by multiplying the time in each health tality into a single index of quality-adjusted life expectancy state by its QOL preference weight to estimate QALYs. (QALE). n The outcomes model is consistent with several QALYs can be added together and estimated over multiple decades of work in rehabilitation medicine. Keith t_-outlined the patients and multiple years. This system has the advantage of need for a new model for rehabilitation nearly 35 years ago.
considering both benefits and side effects of treatment' proOver the years, Keith x3,14has argued for greater use of funcgrams in terms of the common QALY units. tional status outcome measures. Whiteneck et alls offered the Another strength of using QALYs is that they incorporate Craig Handicap Assessment Reporting Technique as a method changes in symptoms and functioning that traditionally have for evaluating outcomes of rehabilitation programs for people been components of rehabilitation evaluations. By measuring a with handicaps. The value of related methods have been dewide spectrum of symptoms and concentrating on function, the scribed in several important lectures and publications, _6-_8
proper assessment of QALYs includes global well-being, inMany of the approaches have been consistent with the World cluding psychologic aspects. Health Organization guidelines and have attended to perforIn addition to health benefits, programs also have costs. mance of role activities. One important reviewS9 considered the Resources are limited, and good policy decisions require allo-
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I t_ cation that maximize life expectancy and health-related QOL To understand the problem better, it is necessary to under-(HRQOL). Methodologies for estimating costs have now bestand the natural history of disease. Pubhc health campaigns come standardized. From an administrative perspective, cost often conceptualize disease as binary. Either persons have the estimates include all costs of treatment and costs associated diagnosis or they do not. However, most diseases are prowith caring for any side effects of treatment. From a social cesses. It is likely that chronic disease begins long before it is perspective, costs are broader and may include costs of family diagnosed. For example, autopsy_studies consistently show that members not working to provide care. Comparing programs for most young adults who died early in life from noncardiovasa given population with a given medical condition, cost effeccular causes have fatty streaks in their coronary arteries that tiveness is measured as the change in costs of care for the indicate the initiation of coronary disease. 3°Not all people who program compared with the existing therapy or program, relahave the disease will ever suffer from the problem. With many tire to the change in health measured in a standardized unit diseases, most of those affected will never even know they are such as the QALY. The difference in costs over the difference sick. in effectiveness is the incremental cost-effectiveness and is
Among those who do have problems, some may not benefit usually expressed as the cost/QALY ratio. Because the objecfrom treatment. This problem is well recognized in rehabilitative of all programs is to produce QALYs, the cost/QALY ratio tion outcomes research.14 However, it may be less well known can be used to show the relative efficiency of different proin other areas of medicine. For example, if smokers are grams, screened forlung cancer, manycasescanbe identified. How-A few recent examples of the application of QALYs in ever, clinical trials have shown that the course of the disease is rehabilitation medicine include an evaluation of the effectivelikely to be the same for those who are screened and those not ness of aggressive care for patients with nontraumatic coma. subjected to screening, even though screening leads to more One study a3 compared the cost-effectiveness of continuing diagnosis and treatment. Although screening identifies cases aggressive care with withholding cardiopulmonary resuscitaearlier, there may be large reservoirs of disease that can be tion and ventilation support after 3 days of coma. The analysis detected through screeningP 1Very high proportions of elderly suggested that aggressive care produced relatively httle health women have ductile breast cancer in situ (DCIS), and nearly benefit but significantly increased cost. As a result, the cost/ 40% of elderly men (>75y) have prostate cancer. 32The harder QALY ratio was very high.
we look, the more likely it is that cases will be found. However, Another example of the use of QALYs is provided by the only about 3% of elderly men will die of prostate cancer, and Stroke Treatment Ancrod Trial. Ancrod is a product developed only about 3% of elderly women will die of breast cancer. from the venom of the Malaysian pit viper. The product may A very sensitive test for prostate cancer may detect disease produce rapid defibrinogenation and, therefore, may have value in 10 men for each 1 man who will eventually die of this for the treatment of stroke. In 1 randomized clinical trial, 24248
condition. These problems are not limited to cancer. Recent patients with acute ischemic strokes received ancrod, whereas autopsy studies suggest that nearly all young men (age range, a control group of 252 patients received placebo. Both groups 15-34y) who die of noncardiovascular causes have some eviwere treated within 90 days poststroke. The analysis showed dence of coronary disease. 3°Advanced magnetic resonance that ancrod treatment both produced health benefit and reduced imaging technology has revealed surprisingly high rates of cost. In other words, the analysis clearly favored the ancrod stroke. One cross-sectional study 33 of 3502 men and women treatment, a4 overage65 foundthat29% had evidenceof mild strokesand A third example is an evaluation of the impact of hip and that 75% had plaque in their carotid arteries, vertebral fractures. In observational data, 2s women free of hip Black and Welch 34make the distinction between disease and or vertebral fractures obtained scores of .91 on the 0 to 1.0 pseudodisease. Pseudodisease is disease that will not affect life scale. Those with 1 or more vertebral fractures obtained scores duration or QOL at any point in a patient's hfetime. When the of .82, whereas those with hip fractures scored .63. Vertebral disease is found, it is often "fixed" with surgical treatment. fracture was equivalent to losing 20 to 28 days a year, whereas However, the fix has consequences, often leaving the patient hip fracture was associated with an estimated loss of 23 to 65
with new symptoms or problems. Many surgeries for patients days a year. The combination hip and vertebral fracture was with SCI, for example, offer few benefits in terms of patient estimated to be the equivalent of losing 115 to 202 days a outcomes. The outcomes model considers the benefits of year. 25 screening and treatment from the patient's perspective. Often, In summary, QALYs combine measures of morbidity and using information provided by patients, we can estimate the mortality and do not require medical diagnoses. The measures QALE for a population and determine if they are better off with include time or prognosis and incorporate preferences for or without screening and treatment. This occurs not only in the definition of the disease, but also in gestions about the use of resources than does the traditional the interpretation of chnical data. _5 By using their experience, biomedical model. Perhaps the best examples concern screenclinicians examine and interpret clinical information. Like any ing for disease. According to the American Cancer Society judgment, these perceptions are not always reliable. For exam-(ACS), it is necessary to screen for cancers so that they can be ple, it is known that physicians are highly variable in their detected early. 27 It is believed that there is a reservoir of interpretation of clinical data. They disagree with one another undetected disease that might be eliminated through more when examining the same clinical information. _6-_8For examaggressive intervention. Screening guidelines have been prople, 1 study 39 evaluated the reliabihty of pathologist-assessed posed, and patients who fail to adhere to these guidelines are DCIS. Six pathologist subjects were given written guidelines regarded as uninformed.2_. 29 and examples of each of the problems for which they were condition. For those who do have disease, there are 3 options: data suggest that there were 34,000 deaths from prostate cancer radical prostatectomy (surgical removal of the prostate gland), in 1996, whereas ACS projected 41,000 expected deaths in external beam radiation, and watchful waiting. 1997.
For men who choose radical prostatectomy, it is Unclear Prostate cancer is the second leading cause of cancer death whether there is a survival benefit) 2 They may gain some relief among men (behind lung cancer). Significant differences of knowing that they have Chosen the most aggressive option. opinion exist about whether the public should invest in screenHowever, there are consequences. Among men receiving fading programs for prostate cancer. The American Urological ical prostatectomy, about 40% will become incontinent, and Association and ACS have promoted large-scale screening of 30% of these will have incontinence that requires the use Of all men older than age 50. 49 These organizations suggest a pads or clamps. Sixty percent of the men who will undergo yearly screening using digital rectal exams or prostate-specific prostatectomy will become impotent, and only about 11% will antigen (PSA). The State of California enacted legislation in have had sexual intercourse in the 30 days before the inter1998requiringphysicians to advise men about the benefits of view._2 prostate cancer screening. Other organizations, including the The traditional model encourages treatment for those with a American College of Physicians, argue that such screening diagnosis. The outcomes model recognizes another option: programs may be of limited benefit 3z,so and that they may be watchful waiting, that is, monitoring the condition without costly, accounting for about 5% of all health care costs, sl treatment. Treatment can be initiated if the disease changes. One of the challenges is in determining whether there really Understanding the value of watchful waiting requires an unis an epidemic of prostate cancer. Figure 1 shows changes in derstanding of the natural history of disease. Computer simuprostate cancer incidence and mortality between 1976 and lations of cohorts of 68-year-old men suggest that the risk of 1994. The number of reported prostate cancer cases doubled distant metastasis is about 5 per 100 patient years. The median over this interval. Following concern about the value of screentime to metastasis is about 14 years. During the 14-year intering, there has been a recent downmrnin incidence. However, val, 58.% of the men will die of other causes before the mortality from prostate cancer has remained relatively condevelopment of metastatic problems from their prostate cancer. stant. One explanation for this apparent discrepancy is that provide control of symptoms and delay disease progression Because time in medical encounters is so limited, shared long enough that many of the men die of other causes before decision making often involves a referral to a decision inbornserious complications from their prostate cancer: 3 tory, The doctor may advise the patient to use a decision aid, By using QALYs as an outcome measure, simulations sugoften under the supervision of another health care professional. gest the benefits of screening are few. For example, Kralm et
Once the patient has interacted with the decision aid, he/she a154estimated the population benefit for programs to screen can return to the physician prepared to deal with the decision in 70-year-old men for prostate cancer. They found that the bena relatively short period of time. efits, on average, were improvements in the life expectancy Although shared decision making is a relative new field, between a few hours and 2 days. However, when they adjusted several decision aids have now been evaluated. In 1 example, the life expectancy for QOL, they discovered that screening Frosch et a157considered a decision aid to help men decide programs reduced quality-adjusted life days. The reason for whether they should be screened for prostate cancer using the this negative impact is that screening identifies many men who PSA test. The men were all enrolled in a clinic that provides a -:'_ would have died of other causes. These men, once identified wide variety of medical screening tests. In an experiment, the with prostate cancer, are then likely to engage in a series of men were randomly assigned to 1 of 4 groups in a 2x2 treatments that would significantly reduce their QOL. For these factorial design. One factor was for use of a decision video. men, the treatment causes harm without producing substantial Men either watched or did not watch a video that systematibenefits, callyreviewedthe risks and benefitsof PSA screening. The video featured a debate between a urologist who favored PSA Shared Decision Making screening and an internist who opposed PSA screening.FurBecause resources are often used to treat pseudodiseases, tiler, the video systematically reviewed the probabilities of health care in the United States has become very expensive. A false positives, false negativesl and the risks of prostate cancer. central component of the problem is that many decisions are It also systematically reviewed the evidence for the benefits of made under conditions of considerable uncertainty. Although treatment for prostate cancer. The other factor in the experipatients accept treatment with high expectations of benefit, mental design was whether men had the opportunity to discuss experienced health care providers may recognize that the pothe decision with others. The design resulted in 4 groups--tential benefit of many treatments is probabilistic, One apusual care, discussion alone, video alone, and video plus disproach to this problem is greater patient involvement in decicussion. AU men were asked if they wanted the PSA test, and sions about care. This section reviews the emerging study of medical records were obtained to determine whether the test shared medical decision making, in which choices of treatment was completed: 7 pathways are a collaborative effort between provider and paThe study showed that there was a systematic effect of the tientY videoanddiscussion groups.In the usualcarecontrolgroup, In an ideal world, a patient could approach a physician with virtually all men (97%) got the PSA test. In other words, with a list of symptoms and Problems. The physician would identify no new information, men will typically take the test. In the the problem and administer a remedy. The service should be other groups, having more information lead to a conservative inexpensive and painless. However, this scenario is uncombias. In contrast to the usual care control, those in the other mon. For most medical decisions, judgments about disease are groups were more sensitive to the risks of the test in relation to not perfectly reliable and, even when an early diagnosis is its benefits. Among those participating in the discussion group, available, it is not always clear that treatment is the best 82% got the PSA test. For those watching the video, 63% option. 36Choices about what treatments should be offered have completed the test. Those watching the video and participating typically been left to the physician. For various reasons, howin those discussions had only a 50% PSA completion rate. The ever, patients are becoming activated in the decision process, study showed that, as patients become better informed, they Shared decision making is the process by which the patients were less likely to take the PSA test. The study also obtained and physicians join in partnership to decide whether the patient information on patient knowledge. As knowledge increased, should undergo diagnostic testing or receive therapy. Often, the likelihood of getting the PSA test decreased, again, stressshared decision making involves formal decision aids that flag that better informed patients make more conservative deprovide patients with detailed information about their options, cisions. The information is usually presented through interactive video Shared decision making may be a valuable tool for rehabildisks, decision boards, descriptive consultations, or through the Ration research and practice. However, a review of the literaInternet. 56 By using these decision aids, patients complete ture failed to identify rehabilitation studies in which the methexercises to inform them of the risks and benefits of treatment ods had been applied. One exception is a well-evaluated options. Sometimes, they provide preferences for outcomes in program on surgery for herniated disks. In this well-controlled the shared decision-making process: 5 study, 58 393 patients with herniated disks, spinal stenosis, or Shared decision making is not patient decision making. In other chronic back problems were randomly assigned to use a other words, there are technical aspects of medical decisions shared decision-making aid or to a control condition. Those in for which patients are not be well equipped. For example, the shared decision-m_ng group felt better informed, and patients are not expected to know what approach to surgery is elected surgery significantly less often than those in the control best or the advantages or disadvantages of particular medicacondition: 8 Although there have been calls for greater use of tions. On the other hand, patients have a perspective that only shared decision making for those with chronic back pain, 59 they fully understand. For instance, surgical treatment for some actual applications in the rehabilitation field remain few. SCIs may increase risk of additional pain. Some patients might CONCLUSION be willing to take the risk, whereas others may prefer to cope with their current condition. The patient provides the perspecThe traditional biomedical model and the outcomes model tive that is typically unknown to the physician. Use of decision differ. One of the most important distinctions is the focus of aids allows these preferences to be expressed. 
